
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/4-AcO-MET: Difference between revisions
Jump to navigation
Jump to search
>Isaak Common names correctly annotated. |
>Mrtryptamine Changed the dosages because they don't accurately reflect what is reported by any other source, including Shulgin and Erowid (4-ho-met) |
||
Line 71: | Line 71: | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose:: | |OralROA_Threshold=[[Oral threshold dose::2]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose:: | |OralROA_Light=[[Oral min light dose::5]] - [[Oral max light dose::10]] mg | ||
|OralROA_Common=[[Oral min common dose:: | |OralROA_Common=[[Oral min common dose::8]] - [[Oral max common dose::15]] mg | ||
|OralROA_Strong=[[Oral min strong dose:: | |OralROA_Strong=[[Oral min strong dose::10]] - [[Oral max strong dose::20]] mg | ||
|OralROA_Heavy=[[Oral heavy dose:: | |OralROA_Heavy=[[Oral heavy dose::25]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= |
Latest revision as of 18:18, 1 May 2025
SubstanceBox/4-AcO-MET | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||||
Common names | 4-AcO-MET, 4-Acetoxy-MET, Metacetin, O-Acetylmetocin | ||||||||||||||||||||||||||||||||
Substitutive name | 4-Acetoxy-N-methyl-N-ethyltryptamine | ||||||||||||||||||||||||||||||||
Systematic name | 3-(2-Ethyl(methyl)aminoethyl)-1H-indol-4-yl acetate | ||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||
Psychoactive class | Psychedelic | ||||||||||||||||||||||||||||||||
Chemical class | Tryptamine | ||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||
|